Indication

SHINGRIX® is indicated to treat:

  • Shingles

Drug Summary

SHINGIRX, Zoster Vaccine Recombinant, is a vaccination used in adults 50 and older for the prevention of shingles (herpes zoster). Administration is a one time dose followed by a second dose administered 2-6 months after first.

 

More Information

For more information, click here to visit the manufacturer’s website: https://www.shingrix.com/index.html

Ready to Start with Specialty Infusion?

It’s easy to transition your treatment to Specialty Infusion. Here’s how it works:

Ask your doctor to send a prescription, clinical notes, demographics and your insurance card.

One of our Care Coordinators will contact you to confirm receipt of your referral and provide guidance on the next steps.

Your Care Coordinator will contact your insurance company to conduct an investigation of benefits and initiate authorization to ensure coverage of your treatment.

Our team works diligently to expedite the authorization process. Once approval is obtained, your Care Coordinator will contact you to schedule an appointment.